Nephros (NEPH) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Nephros (NEPH) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 17.98% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 66.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.58% |
| Mar 31, 2026 | 32.31% |
| Dec 31, 2025 | 50.75% |
| Sep 30, 2025 | 28.08% |
| Jun 30, 2025 | 29.89% |
| Mar 31, 2025 | 31.16% |
| Dec 31, 2024 | 32.27% |
| Sep 30, 2024 | 28.92% |
| Jun 30, 2024 | 38.68% |
| Mar 31, 2024 | 31.01% |
| Dec 31, 2023 | 11.33% |
| Sep 30, 2023 | 47.26% |
| Jun 30, 2023 | 39.63% |
| Mar 31, 2023 | 39.57% |
| Dec 31, 2022 | -48.58% |
| Sep 30, 2022 | -44.29% |
| Jun 30, 2022 | 4.89% |
| Mar 31, 2022 | -0.21% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | -16.97% |